Skip to main content
. Author manuscript; available in PMC: 2023 Nov 24.
Published in final edited form as: Gynecol Oncol. 2022 Sep 30;167(2):213–225. doi: 10.1016/j.ygyno.2022.09.019

Figure 3.

Figure 3.

Association with cyclin E1 H-score and ORR; A. Cohort 1: Platinum resistant, BRCA-wildtype with ≥3 prior lines of therapy; B. Cohort 2: Platinum resistant, BRCA-wildtype with <3 prior lines of therapy; C. Cohort 4: Platinum refractory, BRCA-mutatedor BRCA-wildtype with any number of lines of prior therapy. Subjects with a BOR of NE were excluded. P−values were determined using Student’s t−test. Archival biopsy (grey triangle) was defined as any tissue that was collected more than 28 days before the treatment start date.